Genective
Genective develops and licenses transgenic insect control traits for corn, soy, and cotton, including a novel class of binary pesticidal proteins effective against Fall Armyworm. The company commercializes through licensing to global seed companies and is a wholly-owned subsidiary of Groupe Limagrain.
- Company typePrivate
- Founded2019
- HeadquartersChampaign, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Genective does
Genective is a U.S.-based biotechnology company dedicated to the research, development, and commercialization of transgenic traits for corn, soy, and cotton. The company develops novel insect control solutions through genetic modification, including a proprietary new class of binary pesticidal proteins that target pests such as Fall Armyworm (FAW) and western corn rootworm. Its lead genes have demonstrated efficacy against Fall Armyworm populations that have developed resistance to all currently commercialized insect control solutions, positioning Genective in a market with over $5 billion in annual economic opportunity from pest-related losses. The company holds Excellence Through Stewardship certification and operates R&D infrastructure spanning a global headquarters at the University of Illinois Research Park in Champaign and an in-planta research facility in Weldon, Illinois.
Genective operates a pure B2B licensing model, developing transgenic traits and commercializing them through partnerships and licensing agreements with global seed and agriculture companies. Its commercial reach is materially enabled by its ownership structure: as of June 2025, Genective became a 100% subsidiary of Groupe Limagrain, the world's fourth-largest seed company. Key strategic partners include AgBiome (for coleopteran and lepidopteran trait acceleration), Texas A&M AgriLife Extension, IMAMT, CTC, and the University of Illinois Research Park ecosystem. End customers are downstream farmers growing row crops, reached indirectly through licensed seed partners rather than direct sales.
The company's value proposition centers on novel modes of action for insect resistance management, breakthrough R&D pipeline results, and the ability to deliver a development-deregulation-commercialization pathway for transgenic traits. A team of over 30 scientists with multi-disciplinary expertise in molecular biology, entomology, protein biochemistry, and agronomy, including leadership with prior tenure at Monsanto, Bayer Crop Science, and Provivi, supports the technology platform. As of mid-2025, Genective announced breakthrough pipeline results and full Limagrain ownership consolidation, signaling a transition from pure R&D toward commercial scale-up.
Genective firmographics
Firmographics- Name
- Genective
- Legal name
- Genective
- Website
- https://genective.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Genective develops and licenses transgenic insect control traits for corn, soy, and cotton, including a novel class of binary pesticidal proteins effective against Fall Armyworm. The company commercializes through licensing to global seed companies and is a wholly-owned subsidiary of Groupe Limagrain.
- Ownership category
- akta.pro rank
Genective industry classification
Industry- Product category
- Agricultural Biotechnology
- NAICS
- Pesticide and Other Agricultural Chemical Manufacturing (325320)
- SIC
- Agricultural Chemicals (2870), Patent Owners & Lessors (6794)
- akta.pro primary industry
- Transgenic Trait Development (GM Traits) (AFABALAA)
- akta.pro secondary industries
- Trait Discovery & Functional Genomics (Target ID/Validation) (AFABALAC), Seed Trait Licensing & IP Management (Licensing, freedom-to-operate) (AFABALAJ), Crop Protection Chemicals (Herbicides/Insecticides/Fungicides) (IMAEAEAI)
Keywords
Where Genective is headquartered
LocationHeadquarters
- HQ city
- Champaign
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Genective business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Transgenic Trait Licensing: Genective develops transgenic traits for corn, soy, and cotton and commercializes through licensing agreements and partnerships with global seed and agriculture companies. The company focuses on bringing novel biotech solutions to market through commercial partnerships.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Genective product offering
Product offeringCore offering
Genective develops, deregulates, and commercializes transgenic traits for corn, soy, and cotton that provide novel insect control solutions. The company creates proprietary binary pesticidal proteins and unique modes of action targeting pests such as Fall Armyworm and western corn rootworm. Genective licenses these biotech traits to global seed and agriculture companies for incorporation into commercial seed products.
Product overview
Genective is a biotechnology company dedicated to the research, development, and commercialization of transgenic traits for corn, soy, and cotton. The company's product portfolio centers on developing and delivering novel insect control solutions, including a proprietary class of binary pesticidal proteins and transgenic traits targeting problematic pests such as Fall Armyworm and western corn rootworm. Genective operates as a 100% subsidiary of Groupe Limagrain and leverages partnerships for trait discovery, germplasm access, and breeding resources to accelerate commercialization through industry collaborations.
Differentiator
Problem solved
Functional benefit
Products and services
- Transgenic Corn Traits Genetically modified corn traits for insect control and agricultural enhancement, including novel protein classes targeting resistant pest populations such as Fall Armyworm and western corn rootworm. Licensed to global seed companies for incorporation into commercial corn seed products.
- Transgenic Soy Traits Genetically modified soybean traits developed for improved agricultural performance and pest resistance, licensed to global seed companies for incorporation into commercial soy seed products.
- Transgenic Cotton Traits Genetically modified cotton traits for insect control and enhanced fiber quality, licensed to global seed companies for incorporation into commercial cotton seed products.
- Novel Insect Control Proteins Proprietary binary pesticidal proteins including a new class of insect control proteins effective against Fall Armyworm populations resistant to all currently commercialized solutions. Discovered by Genective as a breakthrough in transgenic insect control.
- Binary Pesticidal Protein Technology Novel binary pesticidal protein technology from Chryseobacterium arthrosphaerae that controls western corn rootworm through a different mode of action than existing commercial pesticidal proteins. Foundation of Genective's insect control portfolio.
Quantifiable outcome
- Created a whole new class of insect control protein that no one else in the industry has
- +1 more outcomes
Companies that use Genective
Customer profileSegments2 records
Ideal customer profiles1 record
Genective technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Genective partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, flagship and minor.
- AgBiomecoreStrategic partnership announced December 11, 2019 to accelerate commercialization of coleopteran and lepidopteran resistant transgenic traits with unique modes of action. The partnership is intended to establish a new leader in insect traits, a market with over $5 billion in annual opportunities. Combines AgBiome's trait discovery platform with Genective's access to key germplasm and breeding resources.
- Groupe Limagrainflagship100% subsidiary of Groupe Limagrain, a French Agri-food conglomerate and world's 4th largest seed company. Limagrain provides unwavering support for Genective's innovation and has positioned the company as a key contributor to agtech innovation.
- Texas A&M AgriLife ExtensionminorPartner logo displayed on partnerships page - academic agricultural research collaboration
- IMAMTminorPartner logo displayed on partnerships page - Brazilian agricultural institute
- CEAminorPartner logo displayed on partnerships page - French atomic energy commission alternative energies
- University of Illinois Research ParkcoreGenective opened global headquarters at University of Illinois Research Park in March 2020. Research Park Executive Director describes Genective as an exemplary member of the innovation community that brought great talent, high-paying jobs, and winning culture. Research Park is committed to supporting Genective's continued achievements as an agtech leader.
Scale indicators4 records
Recent moves8 records
Expansion highlights5 records
Genective competitors and assessment
Company assessmentDirect peers
- KWS: KWS is one of the world's largest seed companies and was Genective's original 50/50 joint venture partner with Limagrain until Genective became a 100% Limagrain subsidiary in 2025. KWS operates competing corn trait development programs and represents the closest historical and operational peer.
- AgBiome: AgBiome is a direct peer and commercialization partner of Genective, also operating in microbial and trait discovery for insect control. Their 2019 strategic partnership combines Genective's germplasm and breeding access with AgBiome's trait discovery platform, making them simultaneously a peer and collaborator in the novel insect control trait space.
Broad incumbents
- Corteva Agriscience: Corteva is a global seed and crop protection incumbent operating one of the largest transgenic insect control trait portfolios through its Pioneer brand. It competes broadly with Genective in corn, soy, and cotton trait development with significantly greater R&D resources and established global seed distribution.
- Bayer Crop Science: Bayer Crop Science (incorporating Monsanto's trait business) operates the dominant Bt transgenic insect control trait portfolio globally across corn, soy, and cotton. It is the broad incumbent against which Genective's novel protein class must compete and is also a likely potential licensing counterparty.
- BASF Agricultural Solutions: BASF's agricultural solutions division operates a transgenic and hybrid trait pipeline for major row crops including corn, soy, and cotton. As a broad incumbent with global seed and trait reach, BASF is a comparable player in the same insect control trait market Genective targets.
- Syngenta: Syngenta is a global ag-input incumbent with an active transgenic trait pipeline for insect control across corn and soy. Its Agrisure and Viptera trait stacks overlap directly with the problem Genective's novel protein class addresses, particularly for Fall Armyworm and corn rootworm.
Emerging players
- Pairwise: Pairwise uses gene editing (CRISPR-based) to develop improved crops, including corn and soy. It is an emerging biotech peer pursuing next-generation seed traits through a different technical pathway (gene editing versus transgenic), representing both a complementary and potentially competing approach to Genective's transgenic platform.
- Inari Agriculture: Inari is a seed design company applying AI and biological engineering to develop next-generation seeds for corn, soy, and wheat. While focused more on yield and sustainability traits than insect control, it represents an emerging biotech peer pursuing transformative seed technology with comparable partnership-driven GTM.
Market position
Strengths2 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Genective social profiles
Digital presenceGenective compliance and trust
Trust signalCompliance1 record
Genective financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genective leadership team
Management profileNumber of profiles
Profiles10 records
Genective funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genective M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genective
What does Genective do?
Genective develops, deregulates, and commercializes transgenic traits for corn, soy, and cotton that provide novel insect control solutions. The company creates proprietary binary pesticidal proteins and unique modes of action targeting pests such as Fall Armyworm and western corn rootworm. Genective licenses these biotech traits to global seed and agriculture companies for incorporation into commercial seed products.
Is Genective a public or private company?
Genective is a private company. It is classified as corporate owned and is currently operating.
When was Genective founded?
Genective was founded in 2019. It employs 11 to 50 people.
Where is Genective based?
Genective is headquartered in Champaign, United States, in the North America region.
How does Genective make money?
One revenue line is on record: transgenic Trait Licensing.
Who are Genective's main competitors?
Direct peers on record are KWS and AgBiome. Broad incumbents are Corteva Agriscience, Bayer Crop Science, BASF Agricultural Solutions and Syngenta. Emerging players are Pairwise and Inari Agriculture.
Does Genective have an API?
No public API is recorded for Genective.
What industry is Genective in?
Genective's product category is Agricultural Biotechnology. Its primary akta.pro industry code is AFABALAA, Transgenic Trait Development (GM Traits), with a secondary code of AFABALAC, Trait Discovery & Functional Genomics (Target ID/Validation). Its NAICS code is 325320 and its SIC code is 2870.